This systematic review and meta-analysis investigates the socioeconomic factors associated with depression treatment outcome regardless of treatment type.
This phase 2 randomized clinical trial investigates the effect of treatment with cognitive behavioral therapy, administered with antidepressant medication, on recurrence prevention when medication treatment is maintained or withdrawn after recovery in adults with major depressive disorder.
Notice of Retraction and Replacement. Hollon et al. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71(10):1157-1164
This randomized clinical trial determines whether a cognitive-behavioral prevention program can reduce the incidence of depressive episodes, increase depression-free days, and improve developmental competence 6 years after implementation among at-risk adolescents.
This meta-analysis examines baseline depression severity as a moderator of treatment outcomes between cognitive behavioral therapy and antidepressant medication.
Hollon et al determine the effects of combining cognitive therapy with antidepressant medications vs antidepressant medications alone on remission and recovery in major depressive disorder. See the editorial by Thase.
Beardslee et al determine whether the positive effects of a group cognitive-behavioral prevention (CBP) program extended to longer-term (multiyear) follow-up.
You currently have no searches saved.